Learn how Benchling is powering the next generation of antibody R&D
Informa and Benchling discuss why antibody therapeutics are on the rise, and how companies are leveraging Benchling’s technology to handle the complexity of modern antibody R&D.
The video covers:
The growing focus on the next generation of immunotherapies
The challenges that these evolving trends pose for immunotherapy and antibody research
How Benchling is helping companies transform their data management